The in vivo effect of Trx inducers has not been studied extensively. We have reported that prostaglandin (PG) E1 enhances Trx expression in H
2O
2-treated cultured RPE cells
31 as well as in the rat RPE layer after ischemia–reperfusion injury.
32 Without oxidative stress, however, PGE1 treatment alone did not enhance Trx expression in vivo and in vitro. Geranylgeranylacetone (GGA) is another Trx inducer in cultured hepatocytes, gastric mucosal cells, and neuronal PC12 cells.
33 34 35 In rat heart, however, a single oral dose of 200 mg/kg GGA did not induce Trx, whereas 50 mg/kg of GGA induced Hsp72.
36 In the present study, intraperitoneal treatment with SF clearly induced Trx in the RPE and neural retina
(Fig. 1)and oral treatment with SF induced Trx in the RPE
(Fig. 2)in mice. Accordingly, SF is a Trx inducer that appears effective in vivo.
Intraperitoneal pretreatment with 0.5 mg SF per day for 3 days was the most effective dose for Trx induction in retinal tissues
(Fig. 1) , and it significantly reduced both the light-induced increases in TUNEL-positive RPE and photoreceptor cells
(Fig. 4)and the loss of these cells
(Fig. 3) . The retinal function estimated with ERGs, the record of the action potential produced by photoreceptor cells (a-wave) and second-order neurons in the inner nuclear layer interacting with Müller glial cells (b-wave), was preserved in SF-treated mice compared with saline-treated control mice after exposure to light
(Fig. 5) . These results suggest that pretreatment with SF attenuates light-induced retinal damage by inhibition of apoptosis and protection of retinal function. Overexpression of Trx in mice attenuates retinal light-induced damage,
16 and induction of Trx by SF may therefore afford cytoprotection against retinal light-induced damage.
Exposure to light enhances lipid peroxidation of the photoreceptor outer segments,
37 and free radicals including reactive oxygen species are thought to be involved in light-induced photoreceptor cell death, because radical trapping agents inhibit the damage.
38 39 Although it is generally thought that Trx is not a direct antioxidant in vivo, it scavenges singlet oxygen and hydroxyl radicals.
40 Trx is a specific hydrogen donor for peroxiredoxin, which eliminates H
2O
2.
41 Elimination of reactive oxygen species and free radicals by Trx in the photoreceptor cell layer may explain the cytoprotective mechanism of SF. The RPE releases several neurotrophic factors,
42 43 and the released neurotrophic factors confer cytoprotection against light-induced photoreceptor cell damage.
6 44 Accordingly, the RPE cell layer is crucial in the maintenance and survival of adjacent photoreceptor cells.
45 46 The induction of Trx was clearly seen in the RPE layer
(Fig. 1) ; therefore, pretreatment with SF attenuates cell damage in the RPE layer
(Figs. 3 4) , and protection of RPE function may be related to the protection of photoreceptor cells by SF.
The Trx promoter region contains several conserved sequences for transcription factors such as oxidative stress responsive element (ORE),
47 ARE,
25 and cyclic AMP responsive element.
13 ORE may not be directly involved in the SF-mediated Trx induction because 10 μM of SF did not induce cell damage
(Fig. 7A)and augmentation of intracellular peroxide production
(Fig. 7B) , whereas 1 μM of SF effectively induced Trx in K-1034 cells
(Fig. 6) . Results of the luciferase reporter assay suggest the involvement of ARE in Trx gene expression by SF in K-1034
(Fig. 8) . In K562 erythroleukemia cells, the NF-E2/small Maf complex constitutively binds to the ARE under unstimulated conditions; Nrf2/small Maf complex binds to ARE when cells are treated with hemin, and this binding induces subsequent Trx gene expression.
25 The Jun/Fos complex binds to the ARE when cells are treated with phorbol 12-myristate 13-acetate (PMA).
25 Thus, a model has been proposed that the ARE of the Trx gene is regulated by a switch in its binding proteins. Binding of the Nrf/small Maf and the Nrf/Jun combinations to the ARE has been reported to be involved in gene expression of phase II protein.
23 24 In EMSA, binding of the transcription factors Nrf2, small Maf (Maf-G -F and -K), and c-Jun (c-Jun, JunB, and JunD) to the ARE of the
Trx gene was observed after SF treatment in K-1034 cells
(Fig. 9) . Thus, ARE and its binding complex also is involved in the mechanisms of Trx induction by SF in RPE cells.
Although SF is not a direct antioxidant, it activates transcription of phase II genes, whose products provide chemically versatile, often catalytic, and prolonged “indirect” antioxidant protection.
48 It is possible that phase II enzymes other than Trx also are involved in SF-mediated cytoprotection against the light-induced retinal damage observed in this study. Taken together with our results and those of previous reports, intensification of endogenous Trx as well as phase II enzymes by SF treatment may be a useful strategy to prevent photooxidative stress-related retinal diseases such as age-related macular degeneration, retinitis pigmentosa, and photic maculopathy.
In summary, intraperitoneal and oral administration of SF upregulates Trx in retinal tissue and mediates cytoprotection against light-induced photoreceptor and RPE cell damage in mice. In cultured RPE cells, SF upregulates the Trx gene through ARE, which was regulated by the Nrf2, small Maf, and c-Jun proteins.
The authors are grateful to Akie Teratani, Ryoko Otsuki, and Yoshimi Yamaguchi for excellent technical assistance.